Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BK polyomavirus (BKPyV), also known as Human polyomavirus 1, is a small, non-enveloped DNA virus belonging to the Polyomaviridae family. It is highly prevalent worldwide and establishes lifelong latency in renal tissues and urinary tract epithelium. Reactivation can cause significant disease in immunocompromised patients, most notably kidney transplant recipients, leading to polyomavirus-associated nephropathy (PVAN) and graft dysfunction/loss. Diagnosis relies on detection of viral DNAemia or viruria using PCR-based assays. Current treatment options are limited, with management focusing on reducing immunosuppression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BK polyomavirus (BKPyV).